Intravenous Tranexamic Acid in Lower Segment Caesarean Section: A Randomized Controlled Trial on Blood Loss

Authors

  • Preeti
  • Jaspinder Pratap Singh
  • Beant Singh

DOI:

https://doi.org/10.69980/ajpr.v28i4.278

Keywords:

Tranexamic acid, Caesarean section, Blood loss, Hematocrit, Randomized controlled trial

Abstract

Introduction: With the rising global incidence of Caesarean sections (CS), managing perioperative blood loss has become a critical concern. Tranexamic acid (TXA), an antifibrinolytic agent, has demonstrated efficacy in reducing blood loss in various surgical procedures. This study evaluates the prophylactic role of TXA in reducing intraoperative and early postoperative blood loss during lower segment Caesarean section (LSCS).

Material and Methods: A single-blind randomized controlled trial was conducted over 18 months at a tertiary care hospital in North India. Seventy term pregnant women undergoing elective or emergency LSCS were randomized into two groups. Group I received 1g intravenous TXA 30 minutes before skin incision, while Group II underwent standard management without TXA. Blood loss was measured intraoperatively and up to two hours postoperatively using both visual and objective methods. Hematocrit levels were assessed preoperatively and on postoperative Day 2. Data were analyzed using SPSS v20, with p<0.05 considered statistically significant.

Results: Group I showed significantly lower intraoperative (306.03 ± 121.21 mL vs. 482.29 ± 162.41 mL) and total blood loss (355.46 ± 122.68 mL vs. 536.86 ± 162.89 mL) compared to Group II (p<0.001). The mean hematocrit drop was also lower in the TXA group (3.08% vs. 4.35%, p<0.001). No patient required blood transfusion or additional uterotonics.

Conclusion: Prophylactic intravenous TXA significantly reduces perioperative blood loss and hematocrit decline during LSCS, supporting its safe and effective use in obstetric surgery.

Author Biographies

Preeti

Senior Resident, Department of Obstetrics and Gynaecology, Kalpana Chawla Medical College and Hospital Karnal.

Jaspinder Pratap Singh

Assistant Professor, Department of Forensic Medicine and Toxicology, Shri Mata Vaishno Devi Institute of Medical Excellence, Katra.

Beant Singh

DNB Resident, Department of Obstetrics and Gynaecology, SBLS Civil Hospital, Jalandhar.

References

1. Kambo I, Bedi N, Dhillon BS, Saxena NC. A critical appraisal of cesarean section rates at teaching hospitals in India. Int J Gynaecol Obstet. 2002;79:151-8.

2. Betran AP, Ye J, Moller AB, Souza JP, Zhang J. Trends and projections of caesarean section rates: global and regional estimates. BMJ Glob Health.2021;6:e005671.

3. Roy A, Paul P, Chouhan P, Rahaman M, Kapasia N. Geographical variability and factors associated with caesarean section delivery in India:a comparative assessment of Bihar and Tamil Nadu. BMC Public Health. 2021;21:1715.

4. Kwawukume E. Caesarean section in developing countries. Best Pract Res Clin Obstet Gynaecol. 2001;15:165-78.

5. Gai MY, Wu LF, Su QF, Tatsumoto K. Clinical observation of blood loss reduced by Tranexamic acid during and after caesarean section: a multicentre randomized trial. Eur J Obstet Gynecol Reprod Biol. 2004;112:154-7.

6. Astedt B. Clinical pharmacology of tranexamic acid. Scand J Gastroenterol. 1987;137:22-5.

7. Farahat MA. Role of intravenous tranexamic acid on cesarean blood loss: a prospective randomized study. J Women's Health. 2019;8:226-30.

8. Oseni RO, Zakari M, Adamou N, Umar UA. Effectiveness of preoperative tranexamic acid in reducing blood loss during caesarean section at Aminu Kano Teaching Hospital, Kano: a randomized controlled trial. Pan Afr Med J. 2021;39(1).

9. Malathi P, Anupama D, Habitha P. Effect of injection Tranexamic acid on perioperative blood loss during Cesarean section. Int Arch Integr Med. 2016;3:280-9.

10. Agarwal N, Lahiri A. Determining the role of prophylactic tranexamic acid in reducing blood loss during and after lower segment caesarean section.J Adv Med Med Res. 2021:153.

11. Mathumitha K, Gopalan U. Role of prophylactic use of tranexamic acid in reducing blood loss during caesarean section in a tertiary care hospital. Indian J Obstet Gynecol Res. 2023;10:126-30.

12. Lakshmi SD, Abraham R. Role of prophylactic tranexamic acid in reducing blood loss during elective caesarean section: a randomized controlled study. J Clin Diagn Res. 2016;10:QC17.

13. Roy I, Chakraborty S, Mukhopadhya S. Role of intravenous tranexamic acid on cesarean blood loss: A prospective randomized study. Trop J Obstet Gynaecol. 2018;35:49-53.

14. Bhagyajyoti, Usharani N, Pratibha A. Role of prophylactic tranexamic acid in reducing blood loss during and after the lower segment caesarean section: a randomized clinical trail. J Cardiovasc Dis Res. 2022;30:43-47.

15. Hancock A, Weeks AD, Lavender DT. Is accurate and reliable blood loss estimation the 'crucial step' in early detection of postpartum haemorrhage: an integrative review of the literature. BMC Pregnancy Childbirth. 2015;15:1-9.

16. Thurer RL, Castro JM, Javidroozi M, Burton K, Bernal NP. Accurate measurement of intraoperative blood loss improves prediction of postoperative hemoglobin levels. J Anesth Clin Res. 2017;8:1-7

Downloads

Published

2025-04-24